| PERIOD ENDING | 27-Sep-09 | 28-Jun-09 | 29-Mar-09 | 31-Dec-08 | | Total Revenue | 2,530,000 | 2,431,000 | 2,439,000 | 3,288,000 | | Cost of Revenue | 2,027,000 | 1,983,000 | 1,994,000 | 2,754,000 | | | Gross Profit | 503,000 | 448,000 | 445,000 | 534,000 | | | Operating Expenses | | Research Development | 90,000 | 79,000 | 85,000 | 102,000 | | Selling General and Administrative | 310,000 | 289,000 | 298,000 | 335,000 | | Non Recurring | 103,000 | (74,000) | 66,000 | (207,000) | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| 154,000 | (4,000) | 304,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 8,000 | (12,000) | (1,000) | (248,000) | | Earnings Before Interest And Taxes | 155,000 | 109,000 | 28,000 | 56,000 | | Interest Expense | 9,000 | 10,000 | 7,000 | 9,000 | | Income Before Tax | 146,000 | 99,000 | 21,000 | 47,000 | | Income Tax Expense | 36,000 | 29,000 | 7,000 | (12,000) | | Minority Interest | (15,000) | (21,000) |
-
| (16,000) | | | | Net Income From Continuing Ops | 95,000 | 49,000 | 14,000 | 43,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 95,000 | 49,000 | 14,000 | 43,000 | | Preferred Stock And Other Adjustments |
-
| 7,000 | (7,000) |
-
| | | Net Income Applicable To Common Shares | $95,000 | $56,000 | $7,000 | $43,000 |
|
0.05% Nasdaq 
Income Statement
